Photothermal therapy in the second near-infrared window (NIR-II, 1000-1700 nm) exhibits a significant advantage over the first near-infrared window (NIR-I, 650-950 nm) in terms of both maximum permissible exposure (MPE) and penetration depth. However, the thus far reported NIR-II photothermal agents (PTAs) have been focused just on inorganic semiconducting and organic polymeric semiconducting nanoparticles. Herein a novel cruciform phthalocyanine pentad was designed, , high photothermal conversion efficiency of 58.3%, and intense photoacoustic signal. Moreover, both in vitro and in vivo studies reveal the good biocompatibility and notable tumor ablation ability of Zn 4 -H 2 Pc/DP NPs under 1064 nm laser irradiation. Theoretical density functional theory calculations interpret the two-dimensional compressional wave energy-dissipation pathway over the broad saddle curved framework of the cruciform conjugated phthalocyanine pentad, rationalizing the efficient photothermal properties of corresponding Zn 4 -H 2 Pc/DP NPs in the NIR-II window.
Introduction
Quite lately, photothermal therapy 1-4 (PTT) in the second nearinfrared (NIR-II, 1000-1700 nm) window has aroused researchers' attention due to its signicant advantage over the rst near-infrared window (NIR-I, 650-950 nm) in terms of both maximum permissible exposure (MPE) and penetration depth. 5, 6 Intensive studies have resulted in reports of a number of inorganic semiconducting and organic polymeric semiconducting material-based photothermal agents (PTAs) in the NIR-II region, such as B-TiO 2Àx -PEG, 7 Sb-doped SnO 2 , 8 Nb 2 C NSs, P1RGD NPs, 10 SPN I-II , 11 and TBDOPV-DT. 12 However, molecular material-based PTAs for the NIR-II window PTT with a well-dened chemical composition and molecular structure still remain unreported due to the difficulty in developing molecular compounds with an absorption band beyond 1000 nm, to the best of our knowledge.
Phthalocyanines (Pcs) are one of the most promising second generation photosensitizers due to their relatively long absorption wavelengths (l max > 650 nm), high extinction coefficients (3 max > 10 5 L mol À1 cm
À1
), and tunable photophysical and photochemical properties through facile chemical modications. [13] [14] [15] In particular, fusing monomeric phthalocyanine units into conjugated dimeric and trimeric frameworks has been revealed to result in a signicant red-shi in the intense Q band adsorption of resulting molecular materials. 16, 17 Further expansion in the oligomeric Pc-conjugated system with the number of Pc units more than three is therefore expected to afford a suitable single molecular material with an intense absorption band beyond 1000 nm, with promising photothermal properties in the NIR-II window.
Herein we report the development of the rst organic molecular material-based photothermal agent Zn 4 -H 2 Pc/DP NPs for NIR-II window tumor photothermal therapy. Firstly, a novel cruciform conjugated phthalocyanine pentad Zn 4 signals were observed for Zn 4 -H 2 Pc/DP NPs, which provided guidance for choosing the optimal time for PTT. In particular, both in vitro and in vivo studies reveal the good biocompatibility and notable tumor ablation ability of Zn 4 -H 2 Pc/DP NPs in the second NIR window. Theoretical calculations by density functional theory interpret the electronic structure and especially the two-dimensional compressional wave uttering energydissipation pathway of 1, rationalizing the efficient photothermal properties of Zn 4 -H 2 Pc/DP NPs in the NIR-II window.
At the end of this section, it is worth noting that for the purpose of enhancing the photothermal conversion efficiency, scientists usually tried to reduce the radiative transition probability as much as possible generally via photoinduced electron transfer, uores-cence resonance energy transfer, and/or molecular stacking. 18, 19 In good contrast, for two-dimensional conjugated materials, a new type of smooth energy-dissipation pathway, i.e. two-dimensional compressional wave uttering over the broad framework, was revealed to be employed to directly and effectively promote the nonradiative decay pathway, realizing intrinsic molecular energy degradation. 20 As a consequence, the corresponding cruciform conjugated phthalocyanine pentad compound,
(1), with a large conjugated framework was fabricated in the present case. In addition, it must be pointed out that the free rotation of peripheral substituents in the molecules of 1 as well as the breathing inter-molecular brillation of the assembled nanostructures also helps to contribute to convert NIR-II light to heat efficiently for Zn 4 -H 2 Pc/DP NPs. Binuclear and trinuclear conjugated phthalocyanine frameworks with red-shied Q-band absorption in the NIR-I region and enhanced extinction coefficients have been developed and characterized. 16, 17 This inspires us to fabricate a further enlarged Pc-based oligomeric conjugated system with an intense absorption band located in the second near-infrared window, beyond 1000 nm. As illustrated in Scheme S1 
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, which may be attributed to the J-aggregates from the self-assembly of phthalocyanine molecules. 21, 22 This also led to the red-shied uorescent emission (l ex ¼ 880 nm, l em ¼ 1108 nm) and signicantly decreased uorescence quantum yield (Q f ¼ 0.2%) for Zn 4 -H 2 Pc/DP NPs. The hydrodynamic diameter of Zn 4 -H 2 Pc/DP NPs was found to be approximately 85 nm (Scheme 1c) via dynamic light scattering (DLS) analysis. Transmission electron microscopy (TEM) and atomic force microscopy (AFM) images also revealed the spherical structure of these nanoparticles with uniform morphology and size with diameters of 40-70 nm as shown in Scheme 1d and e. The suitable z potential of Zn 4 -H 2 Pc/DP NPs [À31 mV, Fig. S6 †] and hydrated diameter of Zn 4 -H 2 Pc/DP NPs enable their easy accumulation in the tumor regions via the enhanced permeability and retention effect. 23 Additionally, the UV-vis-NIR absorption and size distribution for various concentrations of Zn 4 -H 2 Pc/DP NPs prepared were also tested, Fig. S7 -S9. † All these results revealed the high physiological stability of Zn 4 -H 2 Pc/DP NPs, even for those lasting for 73 days, ensuring their promising biomedical applications.
Photothermal properties and photoacoustic imaging performance
The mass extinction coefficient of Zn 4 -H 2 Pc/DP NPs at 1064 nm is 52 L g À1 cm
À1
, Scheme 1b, higher than those of most previously reported NIR-II organic or inorganic PTAs. [7] [8] [9] [10] [11] [12] This indicates the high efficiency of Zn 4 -H 2 Pc/DP NPs in transforming photons into heat in terms of material weight. To directly evaluate the photothermal performance of Zn 4 -H 2 Pc/DP NPs, we measured the concentration-dependent and laser powerdependent photothermal behaviour of the nanoparticles, Fig. 1a and b. Aer 10 min irradiation at 0.9 W cm À2 , the temperature of Zn 4 -H 2 Pc/DP NPs (27 ppm) increased by 24.0 C, see Fig. 1a , which is higher than that for pure water (5.2 C).
Subsequently, according to the data obtained, Fig. 1c Fig. 1d , and no obvious deterioration aer seven cycles of irradiation was observed.
We also explored the tissue-penetration photothermal ability through chicken breast muscles of varying thickness (0, 1, and 4 mm) using Zn 4 -H 2 Pc/DP NPs under 1064 nm laser irradiation. As illustrated in Fig. 1e and S11, † aer 6 min irradiation, the temperature increase of 100 mL Zn 4 -H 2 Pc/DP NPs in a 96-well plate can rapidly reach 56. 6 C without a tissue covering, while that of NPs under 4 mm chicken tissue also showed an increase of 15.2 C with no signicant heating (below 3 C) recorded for the tissue, which exceeded the required temperature rise (13 C) to ablate tumor cells in living mice.
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Photoacoustic (PA) imaging is a new emerging biomedical imaging technology based on light excitation and ultrasonic emission, which is oen accompanied during the photothermal transformation. As a consequence, in this case the PA signals for Zn 4 -H 2 Pc/DP NPs in the agarose gel phantom at various concentrations were recorded from 700 to 960 nm. As can be seen in Fig. 1f and S12, † the PA signal intensity reached the top value at around 900 nm and got enhanced in an almost linear manner along with the increase in the concentration of Zn 4 - H 2 Pc/DP NPs from 9 to 300 ppm. Accordingly PA imaging with NIR-II light has an advantage in both the imaging depth and spatial resolution over the NIR-I light. 23 It is noteworthy that the PA spectrum prole resembles the absorption one (Fig. 1f) of Zn 4 -H 2 Pc/DP NPs, suggesting that the PA signal would be further intensied if the 1048 nm light was employed to excite, since Zn 4 -H 2 Pc/DP NPs show a higher extinction coefficient at this point than that at 900 nm. This implies the good potential of Zn 4 -H 2 Pc/DP NPs for ideally NIR-II PA imaging application. For further investigation via in vivo PA imaging, Zn 4 -H 2 Pc/DP NPs (600 ppm, 50 mL) were intratumorally injected into an MCF-7 tumor-bearing nude mouse and imaged by PA imaging at various time points aer injection. As shown in Fig. S1 , † an intense PA signal was observed in the tumor region aer being injected with Zn 4 -H 2 Pc/DP NPs and was about ten-fold stronger than that before NP injection at a wavelength of 900 nm and reached maximum accumulation aer 4 h, indicating the biocompatibility and physiological stability of Zn 4 -H 2 Pc/DP NPs. The high photothermal performance, excellent photostability, good penetration depth, and intensive PA signal of Zn 4 -H 2 Pc/DP NPs make them an encouraging PA imagingguided PTA for photothermal therapy in the NIR-II window.
Electronic structure and energy transfer
In order to clarify the molecular and electronic structures of Zn 4 -H 2 [Pc(OC 12 H 17 ) 24 ] (1), density functional theory (DFT) calculation was carried out at the level of M06L/6-31G(d). 24 According to the optimized structure, compound 1 employs a saddle curved conformation with an opening angle of $160
, Fig. 2a , as a cooperative result of three forces including (1) the co-planar tendency induced by the supra-conjugating behavior between the neighbouring fused phthalocyanine units, (2) the bending tendency due to the obvious steric hindrance between the peripheral substituents, and (3) the resistance to the excessive bending tendency because of the linking locks via the powerful multihydrogen bonds between the solvent CH 2 Cl 2 and peripheral -OC 12 H 17 groups, Fig. 2b . As can be found in Fig. 2c, (1) located in the range of 1000-1100 nm is assigned mainly to the coupled transitions including HOMO / LUMO (88%), HOMOÀ1 / LUMO+1 (8%), and HOMOÀ4 / LUMO+2 (3%). It is well known that when a molecule is excited by a photon, there are three possible pathways to release energy within the high-energy state including (1) the emission of photons (known as uorescence or phosphorescence), (2) the nonradiative process (generating heat), and (3) the exit from the singlet state (S1) to the triplet state (T1) via spin-inversion, which is responsible for the generation of singlet oxygen. 24 ] at the T1 state with an excitation energy of 0.95 eV (1305 nm).
In addition, according to previous reports, highly ordered molecular stacking within the nanostructure can promote a nonradiative relaxation process by quenching uorescence and reactive oxygen species. 21, 25, 27 This is also true for the present case. When the Zn 4 -H 2 [Pc(OC 12 H 17 ) 24 ] (1) molecules are assembled into nanoparticles, a new thermal vibrational model is introduced by the inter-molecular interactions. As can be seen in Fig. S14 , † the easily occurring breathing between the adjacent van der Waals binding molecules is just at the energy level between 133 and 483 cm À1 (13-48 meV, depending on the binding manner), which also provides a new energy-dissipation pathway, leading to a further reduced uorescence quantum yield of $2& in the region of 1050-1150 nm for the assembled nanostructure of 1. In other words, both the intra-molecular compressional wave uttering and rotational motions of 1 as well as the inter-molecular breathing vibrations in the nanostructure of 1 provide much easier energy-dissipation pathways in comparison with the uorescence-releasing pathway, resulting in $998& energy-loss by means of the nonradiative process (the high entropy production manner) and only $2& energyloss through the uorescence process (the low entropy production manner) in the Zn 4 -H 2 Pc/DP NPs. This in turn leads to nearly vanished uorescence and fully-utilized NIR-II energy, rendering the Zn 4 -H 2 Pc/DP NPs a new molecular material-based PTA for effective NIR-II window photothermal therapy.
Cytotoxicity and photothermal therapy in vitro
The photothermal cytotoxicity of Zn 4 -H 2 Pc/DP NPs was investigated via standard cell viability methylthiazoltetrazolium bromide (MTT) assays. Aer being incubated with Zn 4 -H 2 Pc/DP NPs at various concentrations from 0 to 250 ppm for 24 h, MCF-7 cells showed no discernible cytotoxicity and remained $95% viable even at the Zn 4 -H 2 Pc/DP NP concentration of 250 ppm, Fig. 3a . In contrast, aer exposure to the 1064 nm laser for 1 min (1.5 W cm À2 ), the viability of cells was signicantly decreased with the increasing Zn 4 -H 2 Pc/DP NP concentration, leading to an IC50 value of 74 ppm and revealing the origin of the cytotoxicity from the PTT effect. Furthermore, confocal laser scanning microscopy (CLSM) images of MCF-7 cells co-stained with green-emissive calcine AM and red-emissive propidium iodide (PI) were obtained aer incubation with or without 250 ppm Zn 4 -H 2 Pc/DP NPs. As shown in Fig. 3b and S15, † green uorescence was observed for cells that are treated either with laser irradiation only or with Zn 4 -H 2 Pc/DP NPs in the dark only, indicating the lack of inuence of 1064 nm laser irradiation alone on the viability of MCF-7 cells and the biocompatibility of the Zn 4 -H 2 Pc/DP NPs. On the other hand, red uorescence was obviously imaged for the cells treated with "NPs + laser", agreeing well with the result of the MTT assay as detailed above, revealing the signicant photothermal ablation effect of Zn 4 -H 2 Pc/DP NPs on MCF-7 cells.
Photothermal therapy in vivo
Encouraged by all the above-mentioned results, Zn 4 -H 2 Pc/DP NPs' in vivo photothermal therapy on MCF-7 tumor-bearing nude mice was further evaluated. The mice were randomly divided into two groups (ve mice per group): the group treated with the 1064 nm laser alone (control group) and the one treated with the combination of Zn 4 -H 2 Pc/DP NPs and the 1064 nm laser (NP Group). The change in temperature was monitored using an IR thermal camera during laser irradiation. Aer 4 h post injection, Fig. 4a and b, the tumors with intratumoral injection of Zn 4 -H 2 Pc/ DP NPs (600 ppm, 50 mL per mouse) showed a rapid increase in temperature (from 36.2 to 62.6 C aer 90 s and nally stabilizes at $62 C) when exposed to the 1064 nm laser at 0.6 W cm À2 for 10 min, whereas a slight change in temperature (less than 6 C) of tumor sites was observed for the control group under the same conditions, indicating the excellent photothermal effect of Zn 4 -H 2 Pc/DP NPs. Moreover, the tumor sizes and body weights of each mouse were monitored during the subsequent 20 days, Fig. 4c and d. Distinguishably, tumors in mice injected with Zn 4 -H 2 Pc/DP NPs were eliminated aer 1064 nm laser irradiation, leaving burn scars at the original tumor sites on the 2nd day aer treatment, which fell off aer about two weeks, and no tumor recurrence was observed. In good contrast, tumors in the control group treated with irradiation only showed an obvious growth rate, Fig. 4e and S16. † Moreover, all the mice showed negligible weight uctuation during the observation period, indicating the biocompatibility of Zn 4 -H 2 Pc/DP NPs during the PTT treatment. Hematoxylin and eosin (H&E) staining shows no obvious histopathological damage in major organs from the mouse treated with Zn 4 -H 2 Pc/DP NPs and irradiation, Fig. S17 . † As a result, in vivo treatment experimental results also disclose the efficiency and biocompatibility of Zn 4 -H 2 Pc/DP NPs for PTT in the second NIR window, in line with the in vitro experimental result.
Conclusions
In conclusion, we for the rst time demonstrated a molecular material-based PTA for high-performance tumor ablation in the second NIR window. Associated with the intrinsic spectroscopic nature of the single molecular compound, Zn 4 -H 2 Pc/DP NPs possess a strong NIR absorption, excellent stability against dilution and irradiation, high photothermal conversion efficiency (58.3%) at 1064 nm, and an intense photoacoustic signal, which facilitates the application for NIR-II window PA imagingguided PTT. Both in vitro and in vivo photothermal studies demonstrate the excellence of Zn 4 -H 2 Pc/DP NPs as a PTA for photothermal ablation of tumor cells together with high biocompatibility. The present result not only promises the great potential of Zn 4 -H 2 Pc/DP NPs as a novel photothermal and photoacoustic contrast agent for tumor therapy, but also provides a new strategy towards enhancing the photothermal conversional efficiency of molecular material-based PTAs in the NIR-II window by depending on the signicant two-dimensional compressional wave uttering.
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